Natarajan, Aravind http://orcid.org/0000-0003-2180-7842
Jaroentomeechai, Thapakorn
Cabrera-Sánchez, Marielisa
Mohammed, Jody C. http://orcid.org/0000-0002-3807-8546
Cox, Emily C.
Young, Olivia http://orcid.org/0000-0002-2252-6623
Shajahan, Asif http://orcid.org/0000-0002-4804-1130
Vilkhovoy, Michael
Vadhin, Sandra http://orcid.org/0000-0002-6200-9647
Varner, Jeffrey D.
Azadi, Parastoo
DeLisa, Matthew P. http://orcid.org/0000-0003-3226-1566
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (grant 1S10OD018530, 1R01GM127578-01, supporting grant 1U54CA210184-01)
United States Department of Defense | Defense Threat Reduction Agency (GRANT11631647)
National Science Foundation (CBET-1605242)
Article History
Received: 6 February 2020
Accepted: 16 June 2020
First Online: 27 July 2020
Competing interests
: M.P.D. has a financial interest in Glycobia, Inc. and Versatope, Inc. M.P.D.’s interests are reviewed and managed by Cornell University in accordance with their conflict of interest policies. All authors declare no other competing interests.